Cite
Karakulak UN, Aladag E, Hekimsoy V, et al. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors. Cardiovasc Toxicol. 2020;21(3):216-223doi: 10.1007/s12012-020-09613-2.
Karakulak, U. N., Aladag, E., Hekimsoy, V., Sahiner, M. L., Kaya, E. B., Ozer, N., Aksu, S., Demiroglu, H., Goker, H., Buyukasik, Y., Ozcebe, O., Sayinalp, N., & Haznedaroglu, I. C. (2021). Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors. Cardiovascular toxicology, 21(3), 216-223. https://doi.org/10.1007/s12012-020-09613-2
Karakulak, Ugur Nadir, et al. "Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors." Cardiovascular toxicology vol. 21,3 (2021): 216-223. doi: https://doi.org/10.1007/s12012-020-09613-2
Karakulak UN, Aladag E, Hekimsoy V, Sahiner ML, Kaya EB, Ozer N, Aksu S, Demiroglu H, Goker H, Buyukasik Y, Ozcebe O, Sayinalp N, Haznedaroglu IC. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors. Cardiovasc Toxicol. 2021 Mar;21(3):216-223. doi: 10.1007/s12012-020-09613-2. Epub 2020 Oct 17. PMID: 33068232.
Copy
Download .nbib